Prostate-specific antigen (PSA) testing, digital rectal examinations (DRE), and transrectal ultrasonography (TRUS) guided prostate system biopsies are the most used PCa screening methods in clinics (3, 4), but these diagnostic tools may still lead to a certain degree of overdiagnosis (5). This evidence concerns the gene KLK3 and posterior cortical atrophy.